Younger, Parkitny et McLain, « The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. », Clirheumatology, vol. 33, no 4, , p. 451–9 (PMID24526250, PMCID3962576, DOI10.1007/s10067-014-2517-2)
Segal, Macdonald, JK et Chande, N 9, « Low dose naltrexone for induction of remission in Crohn's disease », The Cochrane Database of Systematic Reviews, vol. 2, no 2, , p. CD010410 (PMID24558033, DOI10.1002/14651858.CD010410.pub2)
Younger, Parkitny et McLain, « The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. », Clirheumatology, vol. 33, no 4, , p. 451–9 (PMID24526250, PMCID3962576, DOI10.1007/s10067-014-2517-2)
Segal, Macdonald, JK et Chande, N 9, « Low dose naltrexone for induction of remission in Crohn's disease », The Cochrane Database of Systematic Reviews, vol. 2, no 2, , p. CD010410 (PMID24558033, DOI10.1002/14651858.CD010410.pub2)
Blach-Olszewska et Leszek, « Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders », Neuropsychiatric Disease and Treatment, vol. 3, no 3, , p. 365–372 (PMID19300567, PMCID2654796)